Zobrazeno 1 - 10
of 127
pro vyhledávání: '"SP Iyer"'
Autor:
DR Zain, SP Iyer, RA Sica, PJ Ho, B Hu, A Prica, W-K Weng, YH Kim, MS Khodadoust, ML Palomba, FM Foss, K Tipton, EL Cullingford, SM Horwitz, A Sharma
Publikováno v:
European Journal of Cancer. 173:S21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53874d30b455ce47a3107db77522a6fc
https://doi.org/10.1016/s0959-8049(22)00591-3
https://doi.org/10.1016/s0959-8049(22)00591-3
Autor:
Prasad R; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Rehman A; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Rehman L; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Darbaniyan F; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Blumenberg V; University Hospital, LMU Munich, Germany., Schubert ML; University Clinic Heidelberg, Germany., Mor U; Weizmann Institute of Science, Rehovot, Israel., Zamir E; German Cancer Research Center (DKFZ), Heidelberg, Germany., Schmidt S; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hayase T; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Chia-Chi C; The University of Texas MD Anderson Cancer Center, United States., McDaniel LK; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Flores I; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Strati P; The University of Texas MD Anderson Cancer Center, United States., Nair R; The University of Texas MD Anderson Cancer Center, United States., Chihara D; The University of Texas MD Anderson Cancer Center, United States., Fayad LE; University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States., Ahmed S; The University of Texas MD Anderson Cancer Center, United States., Iyer SP; The University of Texas MD Anderson Cancer Center, United States., Wang ML; The University of Texas MD Anderson Cancer Center, United States., Jain P; The University of Texas MD Anderson Cancer Center, United States., Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Westin JR; The University of Texas MD Anderson Cancer Center, United States., Arora R; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Turner JG; Moffitt Cancer Center, Tampa, Florida, United States., Khawaja F; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Wu R; The University of Texas MD Anderson Cancer Center, United States., Dennison JB; The University of Texas MD Anderson Cancer Center, United States., Menges M; Moffitt Cancer Center, Tampa, Florida, United States., Hidalgo-Vargas M; Moffitt Cancer Center, Tampa, Florida, United States., Reid KM; Moffitt Cancer Center, Tampa, Florida, United States., Davila ML; Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States., Dreger P; University Clinic Heidelberg, Heidelberg, Germany., Korell F; University Hospital Heidelberg, Heidelberg, Germany., Schmitt A; University Clinic Heidelberg, Germany., Tanner MR; The University of Texas MD Anderson Cancer Center, United States., Champlin RE; The University of Texas MD Anderson Cancer Center, United States., Flowers CR; The University of Texas MD Anderson Cancer Center, United States., Shpall EJ; The University of Texas MD Anderson Cancer Center, United States., Hanash S; The University of Texas MD Anderson Cancer Center, United States., Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Schmitt M; University Clinic Heidelberg, Germany., Subklewe M; University Hospital, LMU Munich, Munich, Germany., Fahrmann J; The University of Texas MD Anderson Cancer Center, United States., Stein-Thoeringer C; University of Tuebingen, Tuebingen, Germany., Elinav E; Weizmann Institute of Science, Rehovot, Israel., Jain MD; Moffitt Cancer Center, Tampa, Florida, United States., Hayase E; The University of Texas MD Anderson Cancer Center, United States., Jenq RR; The University of Texas MD Anderson Cancer Center, United States., Saini NY; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Publikováno v:
Blood [Blood] 2024 Oct 23. Date of Electronic Publication: 2024 Oct 23.
Autor:
Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA. Electronic address: aherrera@coh.org., Zain J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Savage KJ; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Feldman T; Lymphoma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA., Brammer JE; Division of Hematology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Chen L; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Puverel S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Popplewell L; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Budde LE; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Mei M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Hosing C; Department of Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX, USA., Nair R; Department of Lymphoma and Myeloma, UT MD Anderson Cancer Center, Houston, TX, USA., Leslie L; Division of Hematology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Daniels S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Peters L; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Forman S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Rosen S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Kwak L; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Iyer SP; Department of Lymphoma and Myeloma, UT MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Sep; Vol. 11 (9), pp. e671-e681. Date of Electronic Publication: 2024 Jul 24.
Autor:
Gunther JR; Department of Radiation Oncology, The University of TX MD Anderson Cancer Center, TX, USA., Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, TX, USA., Hunt KK; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA., Fang H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, TX, USA., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, TX, USA., Clemens MW; Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, TX, USA., Pinnix CC; Department of Radiation Oncology, The University of TX MD Anderson Cancer Center, TX, USA.
Publikováno v:
Case reports in plastic surgery & hand surgery [Case Reports Plast Surg Hand Surg] 2024 Aug 07; Vol. 11 (1), pp. 2389172. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).
Autor:
Khawaja F; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ahmed S; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Iyer SP; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sassine J; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Infectious Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Handley G; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Division of Infectious Disease and International Medicine, Department of Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Prakash R; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., VanWierren T; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jackson J; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zubovskaia A; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ramdial J; Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rondon G; Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel KK; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Spallone A; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ariza-Heredia EJ; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mulanovich V; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Angelidakis G; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang Y; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chemaly RF; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jul 18; Vol. 11 (8), pp. ofae422. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
Autor:
Bhansali RS; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Ellin F; Department of Internal Medicine, Kalmar County Hospital, Kalmar, Sweden., Relander T; Department of Clinical Sciences Lund, Section for Oncology and Pathology, Lund University, Lund, Sweden.; Department of Oncology, Skane University Hospital, Lund, Sweden., Cao M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Li W; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA., Long Q; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA., Ganesan N; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Stuver R; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Horwitz SM; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Wudhikarn K; Division of Hematology, Mayo Clinic, Rochester, MN.; Division of Hematology and Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Hwang SR; Division of Hematology, Mayo Clinic, Rochester, MN., Bennani NN; Division of Hematology, Mayo Clinic, Rochester, MN., Chavez J; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sokol L; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Saeed H; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Duan F; Department of Medicine, Christiana Care, Newark, DE., Porcu P; Division of Hematologic Malignancies, Thomas Jefferson University, Philadelphia, PA., Pullarkat P; Department of Medicine, Massachusetts General Hospital, Boston, MA., Mehta-Shah N; Division of Hematology/Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO., Zain JM; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA., Ruiz M; Divison of Hematology, The Ohio State University James Comprehensive Cancer Center, Columbus, OH., Brammer JE; Divison of Hematology, The Ohio State University James Comprehensive Cancer Center, Columbus, OH., Prakash R; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Iyer SP; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Olszewski AJ; Division of Hematology/Oncology, Brown University, Providence, RI., Major A; Division of Hematology, University of Colorado Cancer Center, Aurora, CO., Riedell PA; Section of Hematology/Oncology, The University of Chicago, Chicago, IL., Smith SM; Section of Hematology/Oncology, The University of Chicago, Chicago, IL., Goldin C; Department of Hematology and Oncology, Ochsner MD Anderson Cancer Center, Jefferson, LA., Haverkos B; Division of Hematology, University of Colorado Cancer Center, Aurora, CO., Hu B; Department of Hematologic Oncology, Atrium Health, Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC., Zhuang TZ; Winship Cancer Institute at Emory University, Decatur, GA., Allen PB; Winship Cancer Institute at Emory University, Decatur, GA., Toama W; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Janakiram M; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Brooks TR; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Jagadeesh D; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Hariharan N; Division of Blood and Bone Marrow Transplantation, University of California San Diego Moores Cancer Center, San Diego, CA., Goodman AM; Division of Blood and Bone Marrow Transplantation, University of California San Diego Moores Cancer Center, San Diego, CA., Hartman G; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Ghione P; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Fayyaz F; Division of Hematology/Oncology, Northwell Health Cancer Institute, New Hyde Park, NY., Rhodes JM; Division of Hematology/Oncology, Northwell Health Cancer Institute, New Hyde Park, NY., Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Gerson JN; Division of Hematology/Oncology, University of Vermont Cancer Center, Burlington, VT., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Jerkeman M; Department of Clinical Sciences Lund, Section for Oncology and Pathology, Lund University, Lund, Sweden.; Department of Oncology, Skane University Hospital, Lund, Sweden., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3507-3518.
Autor:
Wu SY; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Damron EP; The University of Texas Health Science Center at Houston, Houston, TX, USA., Xu J; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fang PQ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dai J; Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nair R; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Malpica Castillo LE; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fayad LE; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Torres-Cabala CA; Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Medeiros LJ; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vega F; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Miranda RN; Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duvic M; Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pinnix CC; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dabaja BS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iyer SP; Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huen AO; Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gunther JR; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
International journal of dermatology [Int J Dermatol] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.
Autor:
Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jgunther@mdanderson.org., Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhutani MS; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fang PQ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dabaja BS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dong W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhosale PR; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Malpica Castillo L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fayad L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Parmer S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee HJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Samaniego F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Westin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nze CC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Jul; Vol. 11 (7), pp. e521-e529. Date of Electronic Publication: 2024 Jun 03.
Autor:
Lionel AC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gurumurthi A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fetooh A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Eldaya R; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Westin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fayad L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Malpica L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tummala S; Department of Neuro-oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Flowers C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang ML; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 May; Vol. 65 (5), pp. 669-673. Date of Electronic Publication: 2024 Jan 22.
Autor:
Quesada AE; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Electronic address: aquesada@mdanderson.org., Hu S; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Li S; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Toruner GA; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Wei Q; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Ok CY; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Jain P; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Thakral B; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Nwogbo OV; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Kim D; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Iyer SP; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., You MJ; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Medeiros LJ; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Tang G; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Human pathology [Hum Pathol] 2024 Feb; Vol. 144, pp. 71-76. Date of Electronic Publication: 2024 Jan 30.